ICAHN School of Medicine At Mount Sinai
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1963-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.mssm.edu
Optimizing Linkage and Retention to Hypertension Care in Rural Kenya
Not Applicable
Completed
- Conditions
- HypertensionHigh Blood Pressure
- Interventions
- Behavioral: behavioral communication strategyBehavioral: Behavioral communication strategy, plus smartphone-based tool
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2017-10-20
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 1455
- Registration Number
- NCT01844596
- Locations
- 🇰🇪
Moi University School of Medicine, Eldoret, Kenya
YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering
Phase 2
Completed
- Conditions
- Coronary Artery DiseaseObstructive Coronary Artery Disease
- Interventions
- First Posted Date
- 2013-04-23
- Last Posted Date
- 2018-02-13
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 91
- Registration Number
- NCT01837823
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp
Phase 1
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Ingenol Mebutate 0.015%
- First Posted Date
- 2013-04-19
- Last Posted Date
- 2013-12-31
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 20
- Registration Number
- NCT01836367
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Cerebral Oxygen Monitoring During Surgery and Recovery After Surgery in Patients Having Lung Surgery
Terminated
- Conditions
- Cerebral Oxygen Desaturation
- First Posted Date
- 2013-04-18
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 130
- Registration Number
- NCT01835327
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Women's INternational Transcatheter Aortic Valve Implantation Registry
Completed
- Conditions
- Symptomatic Aortic Stenosis
- First Posted Date
- 2013-03-27
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 1019
- Registration Number
- NCT01819181
- Locations
- 🇮🇹
Instituto Clinico Humanitas, Milan, Italy
🇫🇷Hôpital Privé Parly 2, Le Chesnay, France
🇬🇧Imperial College, London, United Kingdom
Methodology Issues in a Tailored Light Treatment for Persons With Dementia
Not Applicable
Completed
- Conditions
- DepressionSleep Disturbances
- Interventions
- Other: Inactive interventionOther: Tailored Active intervention
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 45
- Registration Number
- NCT01816152
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium
Completed
- Conditions
- Early Onset CADFibromuscular Dysplasia
- First Posted Date
- 2013-03-11
- Last Posted Date
- 2013-11-05
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 34
- Registration Number
- NCT01808729
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Systane Ultra Versus Maxidex Versus Saline
Not Applicable
Completed
- Conditions
- Dry Eye Disease
- Interventions
- First Posted Date
- 2013-01-25
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 36
- Registration Number
- NCT01775540
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation
Phase 4
Terminated
- Conditions
- Nicotine Addiction
- Interventions
- Other: Basic Advice + Placebo DrugOther: Scheduled Gradual Reduction + VareniclineOther: Basic Advice + VareniclineOther: Scheduled Gradual Reduction + Placebo Drug
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 32
- Registration Number
- NCT01772641
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 10
- Registration Number
- NCT01740401
- Locations
- 🇺🇸
New York University Langone Clinical Cancer Center, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath